• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Mogroside IIe

Mogroside IIe

Product ID M568264
Cas No. 88901-38-6
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $150.30 In stock
5 mg $420.60 In stock
25 mg $1,141.70 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Mogroside IIe is a minor sweet element of the traditional Chinese medicinal herb Siraitia grosvenori (Luohanguo).

Product Info

Cas No.

88901-38-6

Purity

≥98%

Formula

C42H72O14

Formula Wt.

801.02

IUPAC Name

(2R,3R,4S,5S,6R)-2-[[(3S,8S,9R,10R,11R,13R,14S,17R)-11-hydroxy-17-[(2R,5R)-6-hydroxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-2-yl]-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

Synonym

Mogroside IIe; Mogroside II E; MogrosideIIE; 7-OXOMOGROSIDE II E

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

M568264 MSDS PDF

Info Sheet

M568264 Info Sheet PDF

References

Cai X, He L, Zhou G, et al. Mogroside IIe ameliorates cardiomyopathy by suppressing cardiomyocyte apoptosis in a Type 2 diabetic model. Front Pharmacol. 2021 May 3;12:650193. PMID: 34012399.

Wang L, Yang Z, Lu F, et al. Cucurbitane glycosides derived from mogroside IIe: structure-taste relationships, antioxidant activity, and acute toxicity. Molecules. 2014 Aug 20;19(8):12676-12689. PMID: 25140446.

Xiao J, Huang K, Lin H, et al. Mogroside IIe inhibits digestive enzymes via suppression of interleukin 9/interleukin 9 receptor signalling in acute pancreatitis. Front Pharmacol. 2020 Jun 10;11:859. PMID: 32587518.

Xu F, Li D, Huang Z, et al. Exploring in vitro, in vivo metabolism of mogroside V and distribution of its metabolites in rats by HPLC-ESI-IT-TOF-MS(n). J Pharn Biomed Anal. 2015 Nov 10;115:418-430. PMID: 26280925.

Li D, Ikeda T, Matsuoka N, et al. Cucurbitane glycosides from unripe fruits of Lo Han Kuo (Siraitia grosvenori). Chem Pharm Bull (Tokyo). 2006 Oct;54(10):1425-1428. PMID: 17015982.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • J974440

    JZL184

    MAGL inhibitor.

    ≥98%
  • G3456

    Ginsenoside Rd

    Triterpene saponin found in species of Panax; 2...

    ≥98%
  • B1746

    Belinostat

    HDAC inhibitor.

    ≥98%
  • K0054

    Kanamycin B

    Aminoglycoside; protein translation inhibitor, ...

    ≥98%
  • A6932

    Aristolochic Acid A

    Found in Aristolochia and Radix; PLA2 inhibitor...

    ≥95%
  • C0006

    Cabozantinib

    VEGFR2, c-Met, RET inhibitor.

    ≥98%
  • V0148

    Valproic Acid

    T-type Ca2+ and voltage-gated Na+ channel block...

    ≥98%
  • T5869

    Torcetrapib

    Cholesterol ester transfer protein inhibitor.

    ≥98%
  • P327212

    Pifithrin-α-cyclic Hydrobromide

    p53 inhibitor

    ≥98%
  • R3577

    Ritonavir

    HIV protease inhibitor.

    ≥98%
  • G1210

    GDC-0623

    MEK inhibitor.

    ≥98%
  • P1622

    Pefloxacin Methanesulfonate Dihydrate

    Fluoroquinolone; topoisomerase IV and bacterial...

    ≥98%
  • P0370

    Paromomycin Sulfate

    Aminoglycoside; protein translation inhibitor, ...

    ≥98%
  • Z4833

    ZM-336372

    c-Raf inhibitor, tyrosine kinase inhibitor.

    ≥98%
  • L9704

    LY-2603618

    Chk1 inhibitor.

    ≥98%
  • C291342

    CHIR-99021

    GSK3 inhibitor.

    ≥98%
  • C9614

    Cyclosporin H

    Cyclosporin metabolite; formyl peptide inhibito...

    ≥96%
  • G7346

    GSK-2636771

    p110β PI3K inhibitor.

    ≥98%
  • W0274

    S-(−)-Warfarin Sodium >99%ee

    Coumarin, more potent isomer; VKORC1 inhibitor....

    ≥99%
  • A6229

    Aphidicolin

    Diterpene antibiotic produced by Cephalosporum;...

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only